Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Casein kinase 1 gamma-3 (CSNK1G3) is a member of the CK1 family of serine/threonine protein kinases, characterized by its ability to phosphorylate casein and many acidic proteins[1][4][6]. It is encoded by the CSNK1G3 gene on human chromosome 5q23.2 and functions in diverse cellular processes, including cytokinesis, DNA repair, nuclear localization, protein transport, and especially key roles in **Wnt signaling**, where it phosphorylates the co-receptor LRP6 to promote pathway activation[1][4][7]. CSNK1G3 is widely expressed and implicated in the regulation of fast synaptic transmission via glutamate and potentially other neural processes[1]. Disease links include cancer, sarcosinemia, and specific brain development disorders, though clinical targeting remains investigational[1][5][7].
Inhibition of kinase activity (serine/threonine phosphorylation)[6]. Modulation of Wnt signaling by phosphorylation of pathway components[7][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Casein kinase 1 gamma-3 (CSNK1G3).